Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics**Supported by grant GF 5117 from Ares Serono, Geneva, Switzerland.††Presented in part at the 9th Annual Meeting of the European Society of Human Reproduction and Embriology, Thessaloniki, Greece, June 27 to 30, 1993.-Reference-Cited by-同舟云学术

Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics**Supported by grant GF 5117 from Ares Serono, Geneva, Switzerland.††Presented in part at the 9th Annual Meeting of the European Society of Human Reproduction and Embriology, Thessaloniki, Greece, June 27 to 30, 1993.

Published:1994-04 Issue:4 Volume:61 Page:679-686
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Cotonnec Jean-Yves le,Porchet Hervé Claude,Beltrami Vanya,Khan Azhar,Toon Steeve,Rowland Malcolm

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference11 articles.

1. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH;Le Cotonnec;Fertil Steril,1994

2. In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry;MRI and SART;Fertil Steril,1992

3. In vitro bioassays of follicle-stimulating hormone: methods and clinical applications;Simoni;J Endocrinol Invest,1991

4. FSH isoforms, radioimmunoassays, bioassays, and their significance;Dahl;J Androl,1992

5. Assay of follicle-stimulating hormone based on augmentation with human chorionic gonadotropin;Steelman;Endocrinology,1953

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Analysis of Follicle-Stimulating Hormone During Ovarian Stimulation: Relation with Weight, Prolactin and Gene Polymorphism in THADA and ADIPOQ;Clinical Pharmacokinetics;2023-08-26

2. FSH administration at 12-hour intervals for the first 2 days, combined with mandatory GnRH-agonist trigger and blastocyst vitrification in women (<80Kg) with high AMH levels, results in higher cumulative live birth rates and is safer;Human Fertility;2023-01-16

3. A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose;Journal of Gynecology Obstetrics and Human Reproduction;2023-01

4. Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women;Clinical Drug Investigation;2022-12-07

5. The effect of a single escalating dose of long-acting recombinant human follicle-stimulating hormone Fc fusion protein (KN015) on healthy, pituitary-suppressed women: first-in-human and randomized study on its pharmacokinetics, pharmacodynamics, and tolerability;Expert Opinion on Investigational Drugs;2022-11-02